Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-inc-logo.png&w=240&h=240&zc=2){kind=logo}
EF Hutton Acquisition Co. I reissued their buy rating on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Get Rating) in a research note issued to investors on Friday, Benzinga reports. EF Hutton Acquisition Co. I currently has a $21.00 price objective on the stock. MNMD has been the subject of a number of other reports. […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
– Primary endpoint achieved statistically significant improvement in MDD symptoms – – Confirmation of activity of lysergide in brain health disorders with direct relevance to... | April 14, 2023
Swiss collaborators release topline data showing significant, rapid, and beneficial effects of LSD to alleviate MDD symptoms.
Detailed price information for Mind Medicine Mindmed Inc (MNMD-Q) from The Globe and Mail including charting and trades.